The "Big Five" designation in the global pharmaceutical sector typically refers to the world's largest publicly traded drug manufacturers by revenue and market valuation, which traditionally include multinational giants such as Johnson & Johnson, Eli Lilly, Pfizer, Roche, and Novartis. These industry leaders drive massive global research pipelines, vaccine production, and commercial drug distribution networks.